跳至主要内容
临床试验/TCTR20160107001
TCTR20160107001已完成1 期

Difference in Serum Creatinine Levels In Cervical Cancer Treated Patients With Concurrent Chemoradiation in Songklanagarind Hospital: Intravenous Vs Oral Post-hydration

Department of Obstetrics and Gynecology Faculty of Medicine Prince of Songkla University0 个研究点目标入组 30 人开始时间: 2016年1月7日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
Female

入选标准

  • 1. Cervical cancer patients with proven cell type of squamous cell carcinoma or adenocarcinoma stage II or III (FIGO) without obstructive uropathy underwent concurrent-chemoradiation therapy
  • 2. Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2

排除标准

  • 1.Serum creatinine level prior treatment > 1.2 mg/dl
  • 2.Unstable vital signs
  • 3.Known medical issues: Cardiac diseases, Liver diseases, Renal diseases
  • 4.History of allergy to cisplatin
  • 5.Pregnancy

研究者

发起方
Department of Obstetrics and Gynecology Faculty of Medicine Prince of Songkla University

相似试验